MAPK3 and early-onset autosomal dominant Alzheimer disease: In the Alzheimer’s disease pathway which contained 30 MFS-AD-treating targets, more targets were related to protease and serine/threonine–protein kinase, including two core targets, AKT1 and MAPK3 (Figure 6C).